• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Milestone Pharmaceuticals Inc (NQ: MIST )

    1.840 -0.010 (-0.54%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Milestone Pharmaceuticals Inc

    < Previous 1 2 Next >
    MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q2 2024
    MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q1 2024
    MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    MIST Stock Earnings: Milestone Pharmaceuticals Misses EPS for Q4 2023
    MIST stock results show that Milestone Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Milestone Pharmaceuticals: Q4 Earnings Insights
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
    Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and 
    Via Benzinga
    Why Milestone Pharmaceuticals (MIST) Stock Is Rising
    Milestone Pharmaceuticals shares are trading higher by 19.4% Monday morning. The company announced plans to resubmit the NDA for etripamil to the FDA. 
    Via Benzinga
    Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning! 
    Via InvestorPlace
    Recap: Milestone Pharmaceuticals Q3 Earnings
    Via Benzinga
    Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January
    The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
    Via Benzinga
    Analyst Expectations for Milestone Pharmaceuticals's Future
    Via Benzinga
    Expert Ratings for Milestone Pharmaceuticals
    Via Benzinga
    Milestone Pharmaceuticals: Q1 Earnings Insights
    Via Benzinga
    Milestone Pharmaceuticals's Return On Capital Employed Overview
    Via Benzinga
    Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher
    U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 37,574.66 while the NASDAQ rose 0.50% to 15,068.50. The... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Crude Oil Rises Over 3%; US Home Prices Increase In October
    U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.34% to 37,511.87 while the NASDAQ rose 0.43% to 15,057.13. The... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth... 
    Via Benzinga
    Why Is Heart Disease-Focused Milestone Pharmaceuticals Stock Plummeting Today?
    Milestone Pharmaceuticals Inc (NASDAQ: MIST) announced Tuesday that the Company received a Refusal to File (RTF) letter from the FDA for the New Drug Application seeking approval for self-administered... 
    Via Benzinga
    Exposures Product Safety
    Dow Gains Over 50 Points; Chicago Fed National Activity Index Increases For November
    U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.09% to 37,418.31 while the NASDAQ rose... 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
    Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case. 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.